30-day, Final Federal Register Notice - NRC Form 483

sradovich on DSK3GMQ082PROD with NOTICES

60422

Federal Register / Vol. 82, No. 243 / Wednesday, December 20, 2017 / Notices

in the Application, and relying on the
representations and agreements contained in
the Application, the NRC staff has
determined that EDF is qualified to hold the
ownership interests previously held by
AREVA NP SAS, and that the transfers of
ownership and operating interests to EDF,
described in the Application, are otherwise
consistent with applicable provisions of law,
regulations, and previous NRC orders. These
findings are subject to the conditions set
forth below. The NRC staff further finds that:
(1) The requested change of control will not
be inimical to the common defense and
security or to the health and safety of the
public; and (2) the change of control will be
in accordance with 10 CFR part 51 of the
NRC’s environmental regulations, and all
applicable requirements have been satisfied.
The findings set forth above are supported
by the NRC’s Safety Evaluation Report issued
with this Order.

on the internet the NRC website http://
www.nrc.gov/reading-rm/adams.html.
Persons who do not have access to ADAMS,
or who encounter problems in accessing the
documents located in ADAMS, should
contact the NRC PDR reference staff, by
telephone, at 1–800–397–4209, 301–415–
4737, or via email, to [email protected].
Dated and issued this 14th day of
November, 2017.
For the Nuclear Regulatory Commission.
Marc L. Dapas,
Director, Office of Nuclear Material Safety
and Safeguards.

III
Accordingly, pursuant to Sections 161b,
161i, 183, and 184 of the Act; 42 U.S.C.
2201(b), 2201(i), 2233, and 2234; and 10 CFR
70.36 and 110.50, IT IS HEREBY ORDERED
that the Application regarding the indirect
transfer of control over licenses listed above
from AREVA SA to EDF is approved, subject
to the following conditions:
1. With respect to the licenses listed above,
EDF, as stated in the Application, will abide
by all commitments and representations
previously made by AREVA, Inc. These
include, are not limited to, maintaining
decommissioning records and financial
assurance, implementing decontamination
activities, and eventually decommissioning
the site.
2. The commitments/representations made
in the Application regarding reporting
relationships and authority over safety and
security issues and compliance with NRC
requirements shall be adhered to and may
not be modified without the prior written
consent from the Director, Office of Nuclear
Material Safety and Safeguards, or his
designee.
IT IS FURTHER ORDERED that AREVA,
Inc. at least one (1) business day before all
actions necessary to accomplish the indirect
transfer of control are completed shall so
inform the Director of the Office of Nuclear
Material Safety and Safeguards, in writing. If
the necessary supporting actions have not
been completed by March 31, 2018, this
Order shall become null and void; provided,
however, that, upon timely written
application and for good cause shown, such
completion date may be extended by further
Order.
This Order is effective on issuance.
For further details with respect to this
Order, see the initial Application listed in
Section II above, and the Safety Evaluation
Report supporting this action, which are
available for public inspection at the
Commission’s Public Document Room (PDR),
located at One White Flint North, Public File
Area 01–F21, 11555 Rockville Pike (first
floor), Rockville, Maryland, and accessible,
electronically, through the Agencywide
Documents Access and Management System
(ADAMS) Public Electronic Reading Room,

[NRC–2017–0166]

VerDate Sep<11>2014

21:36 Dec 19, 2017

Jkt 244001

[FR Doc. 2017–27436 Filed 12–19–17; 8:45 am]
BILLING CODE 7590–01–P

NUCLEAR REGULATORY
COMMISSION

Information Collection: Registration
Certificate—In Vitro Testing With
Byproduct Material Under General
License
Nuclear Regulatory
Commission.
ACTION: Notice of submission to the
Office of Management and Budget;
request for comment.
AGENCY:

The U.S. Nuclear Regulatory
Commission (NRC) has recently
submitted a request for renewal of an
existing collection of information to the
Office of Management and Budget
(OMB) for review. The information
collection is entitled, NRC Form 483,
Registration Certificate—‘‘In Vitro
Testing With Byproduct Material Under
General License.’’
DATES: Submit comments by January 19,
2018.
ADDRESSES: Submit comments directly
to the OMB reviewer at: Brandon
DeBruhl, Desk Officer, Office of
Information and Regulatory Affairs
(3150–0038), NEOB–10202, Office of
Management and Budget, Washington,
DC 20503; telephone: 202–395–0710,
email: [email protected].
FOR FURTHER INFORMATION CONTACT:
David Cullison, NRC Clearance Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
[email protected].
SUPPLEMENTARY INFORMATION:
SUMMARY:

I. Obtaining Information and
Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC–2017–
0166 when contacting the NRC about
the availability of information for this
action. You may obtain publicly-

PO 00000

Frm 00054

Fmt 4703

Sfmt 4703

available information related to this
action by any of the following methods:
• Federal rulemaking website: Go to
http://www.regulations.gov and search
for Docket ID NRC–2017–0166.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
http://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to [email protected]. The
supporting statement and the revised
NRC Form 483 are available in ADAMS
under Accession Nos. ML17348B437
and ML17300B398, respectively.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
• NRC’s Clearance Officer: A copy of
the collection of information and related
instructions may be obtained without
charge by contacting the NRC’s
Clearance Officer, David Cullison,
Office of the Chief Information Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
[email protected].
B. Submitting Comments
The NRC cautions you not to include
identifying or contact information that
you do not want to be publicly
disclosed in your comment submission.
The NRC posts all comment
submissions at http://
www.regulations.gov as well as entering
the comment submissions into ADAMS.
The NRC does not routinely edit
comment submissions to remove
identifying or contact information.
If you are requesting or aggregating
comments from other persons for
submission to the OMB, then you
should inform those persons not to
include identifying or contact
information that they do not want to be
publicly disclosed in their comment
submission. Your request should state
that the NRC does not routinely edit
comment submissions to remove such
information before making the comment
submissions available to the public or
entering the comment submissions into
ADAMS.
Background
Under the provisions of the
Paperwork Reduction Act of 1995 (44

E:\FR\FM\20DEN1.SGM

20DEN1

sradovich on DSK3GMQ082PROD with NOTICES

Federal Register / Vol. 82, No. 243 / Wednesday, December 20, 2017 / Notices
U.S.C. Chapter 35), the NRC recently
submitted a request for renewal of an
existing collection of information to
OMB for review entitled, NRC Form
483, ‘‘Registration Certificate—In Vitro
Testing With Byproduct Material Under
General License.’’ The NRC hereby
informs potential respondents that an
agency may not conduct or sponsor, and
that a person is not required to respond
to, a collection of information unless it
displays a currently valid OMB control
number.
The NRC published a Federal
Register notice with a 60-day comment
period on this information collection on
August 28, 2017 (82 FR 40809).
1. The title of the information
collection: NRC Form 483, Registration
Certificate—In Vitro Testing With
Byproduct Material Under General
License.
2. OMB approval number: 3150–0038.
3. Type of submission: Extension.
4. The form number if applicable:
NRC Form 483.
5. How often the collection is required
or requested: There is a one-time
submittal of information to receive a
validated copy of the NRC Form 483
with an assigned registration number. In
addition, any changes in the
information reported on the NRC Form
483 must be reported in writing to the
NRC within 30 days after the effective
date of the change.
6. Who will be required or asked to
respond: Any physician, veterinarian in
the practice of veterinary medicine,
clinical laboratory, or hospital which
desires a general license to receive,
acquire, possess, transfer, or use
specified units of byproduct material in
certain in vitro clinical or laboratory
tests.
7. The estimated number of annual
responses: 6.
8. The estimated number of annual
respondents: 6.
9. An estimate of the total number of
hours needed annually to comply with
the information collection requirement
or request: 1.12 hours.
10. Abstract: Section 31.11 of Title 10
of the Code of Federal Regulations (10
CFR), established a general license
authorizing any physician, clinical
laboratory, veterinarian in the practice
of veterinary medicine, or hospital to
possess certain small quantities of
byproduct material for in vitro clinical
or laboratory test not involving the
internal or external administration of
the byproduct material or the radiation
therefrom to human beings or animals.
Possession of byproduct material under
10 CFR 31.11 is not authorized until the
physician, clinical laboratory,
veterinarian in the practice of veterinary

VerDate Sep<11>2014

21:36 Dec 19, 2017

Jkt 244001

medicine, or hospital has filed the NRC
Form 483 and received from the
Commission a validated copy of the
NRC Form 483 with a registration
number. The licensee can use the
validated copy of the NRC Form 483 to
obtain byproduct material from a
specifically licensed supplier. The NRC
incorporates this information into a
database which is used to verify that a
general licensee is authorized to receive
the byproduct material.
Dated at Rockville, Maryland, this 15th day
of December, 2017.
For the Nuclear Regulatory Commission.
David Cullison,
NRC Clearance Officer, Office of the Chief
Information Officer.
[FR Doc. 2017–27407 Filed 12–19–17; 8:45 am]
BILLING CODE 7590–01–P

NUCLEAR REGULATORY
COMMISSION
[NRC–2016–0274]

Information Collection: Request for
Approval of Official Foreign Travel
Nuclear Regulatory
Commission.
ACTION: Notice of submission to the
Office of Management and Budget;
request for comment.
AGENCY:

The U.S. Nuclear Regulatory
Commission (NRC) has recently
submitted a request for renewal of an
existing collection of information to the
Office of Management and Budget
(OMB) for review. The information
collection is entitled, ‘‘NRC Form 445,
‘‘Request for Approval of Official
Foreign Travel.’’
DATES: Submit comments by January 19,
2018.
ADDRESSES: Submit comments directly
to the OMB reviewer at: Brandon De
Bruhl, Desk Officer, Office of
Information and Regulatory Affairs
(3150–0193), NEOB–10202, Office of
Management and Budget, Washington,
DC 20503; telephone: 202–395–0710,
email: [email protected].
FOR FURTHER INFORMATION CONTACT:
David Cullison, NRC Clearance Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
[email protected].
SUPPLEMENTARY INFORMATION:
SUMMARY:

I. Obtaining Information and
Submitting Comments
A. Obtaining Information
Please refer to Docket ID NRC–2016–
0274 when contacting the NRC about

PO 00000

Frm 00055

Fmt 4703

Sfmt 4703

60423

the availability of information for this
action. You may obtain publiclyavailable information related to this
action by any of the following methods:
• Federal Rulemaking website: Go to
http://www.regulations.gov and search
for Docket ID NRC–2016–0274.
• NRC’s Agencywide Documents
Access and Management System
(ADAMS): You may obtain publiclyavailable documents online in the
ADAMS Public Documents collection at
http://www.nrc.gov/reading-rm/
adams.html. To begin the search, select
‘‘ADAMS Public Documents’’ and then
select ‘‘Begin Web-based ADAMS
Search.’’ For problems with ADAMS,
please contact the NRC’s Public
Document Room (PDR) reference staff at
1–800–397–4209, 301–415–4737, or by
email to [email protected]. The
supporting statement and Request for
Approval of Official Foreign Travel is
available in ADAMS under Accession
No. ML17320A776.
• NRC’s PDR: You may examine and
purchase copies of public documents at
the NRC’s PDR, Room O1–F21, One
White Flint North, 11555 Rockville
Pike, Rockville, Maryland 20852.
• NRC’s Clearance Officer: A copy of
the collection of information and related
instructions may be obtained without
charge by contacting the NRC’s
Clearance Officer, David Cullison,
Office of the Chief Information Officer,
U.S. Nuclear Regulatory Commission,
Washington, DC 20555–0001; telephone:
301–415–2084; email:
[email protected].
B. Submitting Comments
The NRC cautions you not to include
identifying or contact information that
you do not want to be publicly
disclosed in your comment submission.
The NRC posts all comment
submissions at http://
www.regulations.gov as well as entering
the comment submissions into ADAMS.
The NRC does not routinely edit
comment submissions to remove
identifying or contact information.
If you are requesting or aggregating
comments from other persons for
submission to the OMB, then you
should inform those persons not to
include identifying or contact
information that they do not want to be
publicly disclosed in their comment
submission. Your request should state
that the NRC does not routinely edit
comment submissions to remove such
information before making the comment
submissions available to the public or
entering the comment submissions into
ADAMS.

E:\FR\FM\20DEN1.SGM

20DEN1